Program increased number of billable patients by nearly 13% in 90 days, expanding reimbursement potential under evolving 2026 CPT codes TAMPA, Fla., April 22, 2026--(BUSINESS WIRE)--Smart Meter, the ...
The study patients reported improved ability to perform daily, sport, and recreational activities at each time point.
(“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today ...
Results released April 1, 2026, by the American Society for Radiation Oncology (ASTRO), which represents more than 10,000 ...
Dana-Farber Cancer Institute’s study shows predictive value of Ignite Proteomics’ RPPA platform for Enhertu therapy in metastatic breast cancer: Mountain View, California Wedn ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces further compelling evidence from a multicenter, ...
Smith+Nephew (NYSE:SNN) today reported evidence supporting its CartiHeal Agili-C cartilage repair implant technology.
This ASX AI stock could have a very bright future according to analysts at Bell Potter. Here's what you need to ...
Allstate is accusing Surgery Partners, Inc. and a group of Florida surgery centers of running a multimillion-dollar billing ...
Featuring two fresh classes, the best story 'Diablo' has ever had, and many quality-of-life improvements, 'Lord of Hatred' is the ultimate 'Diablo' experience.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results